Unstable angina is a type of coronary artery disease(CAD).

1. A CASE STUDY ON UNSTABLE ANGINA
VIGNAN PHARMACY COLLEGE
(Approved by AICTE, PCI- New Delhi and affiliated to JNTUK)
Vadlamudi, Guntur (dist), pincode: 522213
PRESENTED BY:
Nandini. P
V Pharm D
19AB1T0021
UNDER THE GUIDANCE OF :
Dr. M. Satyavathi
Assistant Professor
Pharm. D

2. Patient Details:
NAME: xxxx
GENDER:
AGE:
DEPARTMENT:
D.O.A:
D.O.D:

3. SUBJECTIVE
C/O
 Chest pain
OBJECTIVE:
PAST MEDICAL HISTORY:
 Hypertension
PAST MEDICATION HISTORY:
 Tab. Telmisartan – 40mg- PO – (1-0-0)
HISTORY OF PRESENT ILLNESS:
Nil
Family/Surgical/Allergies: nil

4. • Physical Examination:
Cardiovascular system: S1 S2 +
Central nervous system: no focal neurological deficit
respiratory system: BAE+
GIT: Soft.
Head, eyes, ears, nose, throat: NAD.
Dermatology: NAD.
Extremities: NAD.
Pharmacist considerations: Nil.
Laboratory investigations
Vitals.
Temperature- 98.3.
BP- 120 / 80.
Pulse-82
RR-22

5. LAB INVESTIGATIONS
PARAMETERS RESULTS REFERENCE
Hb 12.6 12-16.5
PCV 38 35-50
Lymphocytes 43 15-30%
Neutrophils 45 40-70%
Platelets 1.42 1-4 lac/cum
RBC 3.91 3.8-5.8 lac/cum
WBC 5500 4000-11000 cells/ cum
Clotting time 4min 30 sec
Bleeding time 2 min
Sodium 140 135-145 mEq/l
Potassium 4.4 3.5-5.5 mEq/l
Blood Group: O +ve

6. • ECHO:
IMPRESSION: Bilateral enlargement
fair LV systolic function, Grade IV diastolic dysfunction of LV
MAC+ mild sclerosis
TR, MTR/ mild PAH/ TAR, IVC: 1.17 cm- collapsing
DIAGNOSIS:
CAD- Unstable angina
S/P- CAG- mild CAD, slow flow of coronary
ASSESMENT:
Based on the past medical history, chief complaints and abnormal values of the patient was to
diagnose, to have unstable angina.

7. TREATMENT:
S.no TRADE
NAME
GENERIC
NAME
R.O.A DOSE FREQUENCY Day-1 Day-2
1 Tab. Pantop Pantoprazole PO 40mg 1-0-0 ✔ ✔
2 Tab. Gabapin Gabapentin PO 100mg 0-1-0 ✔ ✔
3 Tab. Apigat Apixaban PO 1 tab 0-1-0 ✔ ✔
4 Tab. Metolar Metaprolol PO 25 mg 0-1-0 ✔ ✔
5 Tab.
Ecosprin-AV
Aspirin+
Atorvastatin
PO 75/50mg 0-1-0 ✔ ✔

8. FARM NOTES:
• Finding:- Tab. Apixaban + Tab. Aspirin
Assessment:- increase risk of bleeding
Monitoring:- monitor closely